Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
Cerilliant
McKesson
Queensland Health
Teva
Cantor Fitzgerald
Chubb
Accenture

Generated: April 19, 2018

DrugPatentWatch Database Preview

Tamoxifen citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for tamoxifen citrate and what is the scope of tamoxifen citrate patent protection?

Tamoxifen citrate
is the generic ingredient in three branded drugs marketed by Midatech Pharma Us, Astrazeneca, Actavis Labs Fl Inc, Aegis Pharms, Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms Usa Inc, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Tamoxifen citrate has seven patent family members in seven countries.

There are sixteen drug master file entries for tamoxifen citrate. Fifteen suppliers are listed for this compound.
Pharmacology for tamoxifen citrate
Synonyms for tamoxifen citrate
(2-{4-[1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine; 2-hydroxypropane-1,2,3-tricarboxylic acid
(Z)-(2-(4-(1,2-Diphenylbut-1-enyl)phenoxy)ethyl)dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
(Z)-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate
(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate
(Z)-2-[ p-(1,2-Diphenyl-1-butenyl)phenoxy]- N, N-dimethylethylamine citrate (1:1)
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-ethanamine cirtrate (1:1)
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate
{2-[4-((1Z)-1,2-diphenylbut-1-enyl)phenoxy]ethyl}dimethylamine, 2-hydroxypropa ne-1,2,3-tricarboxylic acid
{2-[4-(1,2-diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate (salt)
10540-29-1 (Parent)
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
54965-24-1
7244-97-5
7FRV7310N6
965T241
AB0006810
AB2000015
AC1MBZ3O
AK139137
AKOS005111126
ARONIS23853
BCP0726000223
CAS-54965-24-1
CCG-39629
CCRIS 6718
CHEMBL786
CITRIC ACID; TAMOXIFEN
citro; tamoxifen
CPD000677949
CS-1852
D00966
DSSTox_CID_1301
DSSTox_GSID_21301
DSSTox_RID_76068
DTXSID8021301
EINECS 259-415-2
Emblon
Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate
Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Ethanamine,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Ethylamine, 2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, citrate (Z)-
EU-0101203
Farmifeno
FQZYTYWMLGAPFJ-OQKDUQJOSA-N
Genox
Ginarsan
HMS1568M14
HMS1921C13
HMS2092K17
HMS2095M14
HMS2232E08
HMS3263B08
HMS500M20
HY-13757
I.C.I. 46474 citrate
ICI 46,474
ICI 46474
Istubal
J10303
Jenoxifen
K-9859
KB-80806
KS-5046
Ledertam
Lopac-T-9262
LP01203
LS-68202
M936
MFCD00058321
MLS001055370
MLS002154210
N,N-Dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)ethylamine citrate
NCGC00016206-01
NCGC00016206-02
NCGC00016206-03
NCGC00016206-04
NCGC00016206-05
NCGC00016206-06
NCGC00024928-02
NCGC00024928-06
NCGC00024928-23
NCGC00094450-01
NCGC00094450-02
NCGC00094450-03
NCGC00094450-04
NCGC00254000-01
NCGC00259619-01
NCGC00261888-01
Nolgen
Nolvadex (TN) (AstraZeneca)
Nourytan
Noxitem
NSC-180973
NSC-757345
NSC180973
NSC757345
Oncotam
OR076576
OR183555
Pharmakon1600-01500557
Prestwick_458
Q-201776
s1238
s1972
SAM002564256
SBB080554
SC-13399
SCHEMBL6365
SMR000677949
SPECTRUM1500557
SR-01000075523
SR-01000075523-5
ST51039035
T 9262
Tafoxen
Tamax
Tamoplex
Tamox-Puren
Tamoxasta
Tamoxifen (Citrate)
Tamoxifen (Nolvadex)
Tamoxifen citrate (JP17/USP)
Tamoxifen Citrate (Nolvadex)
Tamoxifen citrate for performance test, European Pharmacopoeia (EP) Reference Standard
Tamoxifen citrate salt
Tamoxifen citrate salt, >=99%
Tamoxifen citrate, European Pharmacopoeia (EP) Reference Standard
Tamoxifen citrate, United States Pharmacopeia (USP) Reference Standard
Tamoxifen, citrate salt
Tamoxifencitrate
Taxus
Terimon
Tox21_110938
Tox21_110938_1
Tox21_202070
Tox21_300274
Tox21_501203
trans-1-(p-beta-Dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene citrate
UNII-7FRV7310N6
Z-Tamoxifen citrate
Zitazonium
Zynoplex

US Patents and Regulatory Information for tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aegis Pharms TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 076398-001 Mar 31, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Midatech Pharma Us SOLTAMOX tamoxifen citrate SOLUTION;ORAL 021807-001 Oct 29, 2005 RX No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Teva TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074504-001 Apr 28, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mayne Pharma TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 075797-002 Feb 20, 2003 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca NOLVADEX tamoxifen citrate TABLET;ORAL 017970-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca NOLVADEX tamoxifen citrate TABLET;ORAL 017970-002 Mar 21, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Medtronic
Citi
Express Scripts
Cantor Fitzgerald
Baxter
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.